ERBB2 and breast carcinoma: In this study we have used the recombinant form of the human βGBP cytokine to investigate its effect in aggressive cancer cells where the ErbB2 oncoprotein receptor is overexpressed, taking as a paradigm cancer of the breast, known for high mutation frequency in the gene encoding the p110α subunit of PI3K [22,25].